Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
Back

Academic and Research Skills

Artificial Intelligence

Basic Science

Core Curriculum for Fellows

Developmental Biology

Global Neonatal & Children's Health

Neonatology

Telemedicine

Trainee

PAS Post-Graduate Course: Neo ROP: You Saved the Baby, But Can We Save The Sight?

PANEL DISCUSSION: The Great Debate- to Avastin or Not to Avastin?

Friday, April 25, 2025
9:05am – 9:20am HST
Location:  Convention Center: 305

    Speaker(s)

  • Mary Elizabeth Hartnett, MD, FACS, FARVO (she/her/hers)

    Michael F. Marmor, MD, Professor of Retinal Science and Disease Professor of Ophthalmology, Vitreoretinal Service and Surgery Principal Investigator Retinal Angiogenesis Laboratory
    Stanford University School of Medicine
    San Carlos, California, United States

  • Faizah Bhatti, MD, MS (she/her/hers)

    Associate Professor
    Oklahoma Childrens Hospital at OU Health
    Oklahoma City, Oklahoma, United States

  • JC

    J. Peter Campbell, MD, MPH (he/him/his)

    Associate Professor of Ophthalmology
    Oregon Health & Science University School of Medicine
    Portland, Oregon, United States

  • AC

    Alison Chu, MD

    University of California, Los Angeles David Geffen School of Medicine
    Los Angeles, California, United States

Disclosure(s):
Mary Elizabeth Hartnett, MD, FACS, FARVO: Feliqs (Ongoing) (Products/Services: Consultant); Jack McGovern Coats Disease Foundation (Ongoing) (Products/Services: Board Member or Executive Role); Johnson and johnson (Ongoing) (Products/Services: Consultant); national institute of health (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Ray therapeutics (Ongoing) (Products/Services: Advisory Committee)
Faizah Bhatti, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
J. Peter Campbell, MD, MPH: Siloam Vision (Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Alison Chu, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.